Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benidipine vs Hydrochlorothiazide in Fosinopril-Treated CKD
NCT02646397Phase 4Unknown
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) and hypertension (HTN) comparing Fosinopril + Benidipine with Fosinopril + Hydrochlorothiazide (2 arms). Primary endpoint: Changes in estimated glomerular filtration rate at 6 months. Status: unknown.
02
Drugs
benidipinehydrochlorothiazide
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT02646397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646397.